Morgan Stanley Warns Warner Chilcott's DELZICOL 'May Not Qualify for Any Marketing Exclusivity'

Traders in Warner Chilcott (NASDAQ: WCRX ) may be considering an earlier concerning note from Morgan Stanley following news of FDA approval for DELZICOL. After trading to an intraday high at $14.87, shares of Warner Chilcott last traded around $14.27, up about 1.4 percent from Monday's close. Morgan Stanley analysts